Abbott Laboratories (ABT) Q4 2023 Earnings Call Transcript
https://www.fool.com/earnings/call-transcripts/2024/01/24/abbott-laboratories-abt-q4-2023-earnings-call-tran/?source=iedfolrf0000001
Jan 24, 2024 - ABT earnings call for the period ending December 31, 2023.
0
5 stocks to watch on Wednesday: LLY, ABT and more
https://seekingalpha.com/news/4090463-5-stocks-to-watch-on-wednesday-lly-abt-and-more?source=feed_sector_healthcare
Apr 17, 2024 - Eli Lilly (LLY), Abbott Laboratories (ABT), Travelers (TRV), Capri (CPRI) and Tapestry (TPR) are the stocks to watch on Wednesday.
0
Abbott Laboratories (ABT) 42nd Annual J.P. Morgan Healthcare Conference Call Transcript
https://seekingalpha.com/article/4662007-abbott-laboratories-abt-42nd-annual-j-p-morgan-healthcare-conference-call-transcript?source=feed_sector_transcripts
Jan 09, 2024 - Abbott Laboratories (NYSE:NYSE:ABT) 42nd Annual J.P.
0
Abbott Laboratories (ABT) Q1 2024 Earnings Call Transcript
https://www.fool.com/earnings/call-transcripts/2024/04/17/abbott-laboratories-abt-q1-2024-earnings-call-tran/?source=iedfolrf0000001
Apr 17, 2024 - ABT earnings call for the period ending March 31, 2024.
0
PETQ vs. ABT: Which Stock Is the Better Value Option?
https://www.zacks.com/stock/news/2194350/petq-vs-abt-which-stock-is-the-better-value-option?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2194350
Dec 06, 2023 - PETQ vs. ABT: Which Stock Is the Better Value Option?
0
Abbott (ABT) Advances But Underperforms Market: Key Facts
https://www.zacks.com/stock/news/2197054/abbott-abt-advances-but-underperforms-market-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v1-2197054
Dec 12, 2023 - Abbott (ABT) concluded the recent trading session at $106.68, signifying a +0.43% move from its prior day's close.
0
3 Dividend Growers Suited for Income Investors
https://www.zacks.com/commentary/2207189/3-dividend-growers-suited-for-income-investors?cid=CS-ZC-FT-investment_ideas-2207189
Jan 08, 2024 - A company's ability to consistently pay and increase dividend payouts reflects a stable and healthy financial position. Who doesn't enjoy payday?
0
Abbott (ABT) Advances While Market Declines: Some Information for Investors
https://www.zacks.com/stock/news/2207832/abbott-abt-advances-while-market-declines-some-information-for-investors?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v2-2207832
Jan 09, 2024 - Abbott (ABT) closed at $112.73 in the latest trading session, marking a +0.29% move from the prior day.
0
Seeking Clues to Abbott (ABT) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics
https://www.zacks.com/stock/news/2213031/seeking-clues-to-abbott-abt-q4-earnings-a-peek-into-wall-street-projections-for-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2213031
Jan 19, 2024 - Beyond analysts' top -and-bottom-line estimates for Abbott (ABT), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2023.
0
What's in Store for Zimmer Biomet (ZBH) in Q4 Earnings?
https://www.zacks.com/stock/news/2213563/what-s-in-store-for-zimmer-biomet-zbh-in-q4-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2213563
Jan 22, 2024 - Zimmer Biomet (ZBH) is expected to have gained from the uptake of Persona OsseoTi Keel Tibia for Cementless Knee Replacement in the fourth quarter.
0
Page 1>